0.687
17.72%
-0.148
시간 외 거래:
.70
0.013
+1.89%
Eterna Therapeutics Inc (ERNA) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
176.47%
0.047
|
0.017 | 0.051 | - | - |
Cost Of Revenue |
7.58%
0.061
|
0.066 | 0.12 | - | - |
Gross Profit |
71.43%
-0.014
|
-0.049 | -0.069 | - | - |
Operating Expenses |
1.00%
5.773
|
5.716 | 5.436 | 4.549 | 5.316 |
Benefits Costs and Expenses |
8.36%
6.69
|
6.174 | 5.65 | - | - |
Costs And Expenses |
8.36%
6.69
|
6.174 | 5.65 | - | - |
Operating Income/Loss |
0.38%
-5.787
|
-5.765 | -5.505 | -4.549 | -5.316 |
Nonoperating Income/Loss |
118.37%
-0.856
|
-0.392 | -0.094 | 0.045 | -0.095 |
Income/Loss From Continuing Operations Before Tax |
7.89%
-6.643
|
-6.157 | -5.599 | -4.504 | -5.411 |
Income Tax Expense/Benefit |
200.00%
0.004
|
-0.004 | -0.008 | 0.004 | 0.005 |
Income/Loss From Continuing Operations After Tax |
8.03%
-6.647
|
-6.153 | -5.591 | -4.508 | -5.416 |
Net Income/Loss
|
8.03%
-6.647
|
-6.153 | -5.591 | -4.508 | -5.416 |
Preferred Stock Dividends And Other Adjustments |
100.00%
-
|
0.008 | - | 0.008 | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
16,294%
5.41
|
0.033 | 5.41 | 5.303 | 5.127 |
Diluted Average Shares |
16,294%
5.41
|
0.033 | 5.41 | 5.303 | 5.127 |
Basic Earnings Per Share |
7.89%
-1.23
|
-1.14 | -1.03 | -0.85 | -1.06 |
Diluted Earnings Per Share |
7.89%
-1.23
|
-1.14 | -1.03 | -0.85 | -1.06 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
100.00%
-
|
0.008 | - | 0.008 | - |
자본화:
|
볼륨(24시간):